From latent to patent: rethinking prediction of tuberculosis. (2017)

First Author: Cobelens F

Attributed to: Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(16)30419-2

PubMed Identifier: 28017341

Publication URI: http://europepmc.org/abstract/MED/28017341

Type: Journal Article/Review

Volume: 5

Parent Publication: The Lancet. Respiratory medicine

Issue: 4

ISSN: 2213-2600